Overexpression of eIF5A‐2 is an adverse prognostic marker of survival in stage I non–small cell lung cancer patients

Liru He(Sun Yat-sen University), Dan Xie(The Eighth Hospital of Xi'an), Xin‐Yuan Guan(Sun Yat-sen University), Binkui Li(Sun Yat-sen University), Yan‐Hui Liu(Hainan University), Yi‐Xin Zeng(Sun Yat-sen University), Hongyun Zhao(Sun Yat-sen University), Meng‐Zhong Liu(Sun Yat-sen University), Xiu‐Wu Bian(Army Medical University)
International Journal of Cancer
September 9, 2010
Cited by 95


Related Papers